[Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
Koning
S
S
Thomas
S
S
van der Wouden
J C
JC
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D005672:Fusidic Acid / Q000494:pharmacology*; D006761:Hospitals; D006801:Humans; D009666:Nose / Q000382:microbiology; D012867:Skin / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D013997:Time Factors; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D005672:Fusidic Acid